生物科技公司初期投資實戰寶典

????? 無論聘請多少律師和會計，醫藥行業的結構性投資都會有較長的醞釀時間。不要認為你能大大加快這一過程。如果一家大型醫藥公司告訴你他們正在剝離一部分資產，而且讓你看了初步清單，你可以認為，這項工作需要10-20個月左右才能完成，特別是在資產剝離涉及整合細節復雜的結構性回購的情況下。在醞釀過程中還需要和手續繁雜的大型政府機構打交道，同時建立復雜的交易結構。

????雖然在回顧以往教訓時我們沒有出現如夢方醒的感受（希望實際情況就是如此），但我們發現，每隔幾年就回顧一下這些教訓，同時加以補充對我們確有幫助。而且在開展新的投資，迎接相應挑戰的過程中，我們確實會把這些教訓拿出來，時不時地互相輕輕敲打一下，以便彼此提醒。

????作者布魯斯?布斯是信息科技和生命科學投資公司Atlas Venture合伙人。他的博客地址是www.lifescivc.com。

????譯者：濤

????? Structured deals with Pharma have a long gestation time, no matter how many lawyers and accountants are in the room. Don't assume you can speed them up too much. When Big Pharma XYZ tells you they are spinning out some assets and they show you the initial list, assume it's going to take something in between a human and a pachyderm pregnancy to get to the closing, especially if there's a structured buyback with complex consolidation details included. This gestation just comes with the territory of large bureaucratic organizations and complicated deal structures.

????While we've had no major "Ah-ha" moments in reviewing our Lessons Learned (wish it were that easy), we do find that revisiting and updating them every few years is helpful. And during our champion and challenge process for new deals, we do bring up these lessons to gently bludgeon each other once in a while.

????Bruce Booth is a partner with Atlas Venture. He blogs at www.lifescivc.com